United States · Bill · S
S. 1803 (115th)
MEDS Act
Introduced
13 September 2017
Last action
—
Status
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S5483-5484)
Sponsors
—
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Marijuana Effective Drug Studies Act of 2017 or the MEDS Act This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana. Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 13 September 2017
Introduced in Senate (PDF)
Introduced in Senate · EN · 13 September 2017
Introduced in Senate
summary · EN · 13 September 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/1803
- Open data entity: https://api.congress.gov/v3/bill/115/s/1803